Pulmonary vascular disease

Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
Sri Harsha Dintakurti, Sanjana Kamath, Ciara Mahon, Suveer Singh, Bhavin Rawal, Simon P.G. Padley, Anand Devaraj, Laura C. Price, Sujal R. Desai, Tom Semple, Carole A. Ridge

ERJ Open Research Jan 2023, 9 (1) 00389-2022; DOI: 10.1183/23120541.00389-2022
Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
Vitaly O. Kheyfets, Andrew J. Sweatt, Mardi Gomberg-Maitland, Dunbar D. Ivy, Robin Condliffe, David G. Kiely, Allan Lawrie, Bradley A. Maron, Roham T. Zamanian, Kurt R. Stenmark

ERJ Open Research Jan 2023, 9 (1) 00484-2022; DOI: 10.1183/23120541.00484-2022
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) – a cohort study
Carol Keen, Ian Smith, Molly Hashmi-Greenwood, Karen Sage, David G. Kiely

ERJ Open Research Jan 2023, 9 (1) 00295-2022; DOI: 10.1183/23120541.00295-2022
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
J. Gerry Coghlan, Sean Gaine, Richard Channick, Kelly M. Chin, Camille du Roure, J. Simon R. Gibbs, Marius M. Hoeper, Irene M. Lang, Stephen C. Mathai, Vallerie V. McLaughlin, Lada Mitchell, Gérald Simonneau, Olivier Sitbon, Victor F. Tapson, Nazzareno Galiè

ERJ Open Research Jan 2023, 9 (1) 00456-2022; DOI: 10.1183/23120541.00456-2022
When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
Shannon Niedermeyer, Paul Hassoun

ERJ Open Research Jan 2023, 9 (1) 00592-2022; DOI: 10.1183/23120541.00592-2022
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension
Prem Bhattarai, Wenying Lu, Archana Vijay Gaikwad, Surajit Dey, Collin Chia, Josie Larby, Greg Haug, Ashutosh Hardikar, Andrew Williams, Gurpreet Kaur Singhera, Tillie-Louise Hackett, Mathew Suji Eapen, Sukhwinder Singh Sohal

ERJ Open Research Oct 2022, 8 (4) 00254-2022; DOI: 10.1183/23120541.00254-2022
Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
Sebastiaan Dhont, Bert Zwaenepoel, Els Vandecasteele, Guy Brusselle, Michel De Pauw

ERJ Open Research Oct 2022, 8 (4) 00272-2022; DOI: 10.1183/23120541.00272-2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension
Roberto Badagliacca, Michele D'Alto, Stefano Ghio, Paola Argiento, Natale Daniele Brunetti, Gavino Casu, Nadia Cedrone, Marco Confalonieri, Marco Corda, Michele Correale, Carlo D'Agostino, Lucrezia De Michele, Serena Di Marino, Domenico Filomena, Giuseppe Galgano, Alessandra Greco, Carlo Lombardi, Giovanna Manzi, Valentina Mercurio, Massimiliano Mulè, Giuseppe Paciocco, Silvia Papa, Emanuele Romeo, Laura Scelsi, Davide Stolfo, Patrizio Vitulo, Carmine Dario Vizza

ERJ Open Research Oct 2022, 8 (4) 00298-2022; DOI: 10.1183/23120541.00298-2022
Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
Ioannis T. Farmakis, Elena Vrana, Sophia-Anastasia Mouratoglou, Stefanos Zafeiropoulos, Stavros Zanos, George Giannakoulas

ERJ Open Research Oct 2022, 8 (4) 00313-2022; DOI: 10.1183/23120541.00313-2022
Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
Alexandra N. Linder, Jill Hsia, Sheila V. Krishnan, Erika B. Rosenzweig, Usha S. Krishnan

ERJ Open Research Oct 2022, 8 (4) 00223-2022; DOI: 10.1183/23120541.00223-2022

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us